Clinical Trials Logo

Filter by:
NCT ID: NCT01570725 Withdrawn - Anxiety Clinical Trials

Virtual Reality to Reduce Anxiety in Ambulatory Surgical Operations

VRSurg
Start date: October 2008
Phase: N/A
Study type: Interventional

Background. Preoperative anxiety is a common problem for patients who undergo surgical operations, being often associated with a number of negative behaviours during and after the surgical experience. Since drug treatments alone have frequently proved to be inadequate to reduce stress and anxiety in surgical contexts, in the last decades there has been an increased interest in non invasive complementary and alternative medical therapies (CAM), including music, relaxation, guided imagery, hypnosis, etc. that reduce pain and tension during pre and post operative phases. Virtual reality can be considered an innovative form of e-health-based CAM therapy having gained recognition as a means of attenuating pain during medical procedures. VR reduces distress and pain perception by providing a particularly intense form of immersive distraction that taxes the patient's limited attention capacity, resulting in the withdrawal of attention from the real, noxious, external stimulus with a subsequent reduction in pain and stress. Objective. The aim of this study is to test the efficacy of a small, portable and immersive virtual reality system to reduce anxiety in a sample of patients who underwent ambulatory surgical operations under local or regional anaesthesia.

NCT ID: NCT01568242 Withdrawn - Clinical trials for Proliferative Diabetic Retinopathy

Changes in Vitreous Temperature During Phacoemulsification

Start date: February 2012
Phase: N/A
Study type: Interventional

Temperature in the vitreous cavity decreases during vitrectomy, and the same effect is seen during an uneventful phaco surgery. Significant changes occur between the baseline temperature and after every step of the surgery.

NCT ID: NCT01541904 Withdrawn - Clinical trials for Conjunctivitis, Allergic

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

PRO-118
Start date: March 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118 ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal (SAC) and perennial (PAC) allergic conjunctivitis.

NCT ID: NCT01502514 Withdrawn - Clinical trials for Ischemic Congestive Heart Failure

Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure

Start date: May 2011
Phase: Phase 1
Study type: Interventional

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients with Heart Disease as assessed by a series of measurements indicating improvement, stability, or degradation of a patient's cardiovascular function and exercise capacity?

NCT ID: NCT01502501 Withdrawn - Clinical trials for Non-Ischemic Congestive Heart Failure

Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure

Start date: May 2011
Phase: N/A
Study type: Interventional

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients with Heart Disease as assessed by a series of measurements indicating improvement, stability, or degradation of a patient's cardiovascular function and exercise capacity?

NCT ID: NCT01501461 Withdrawn - Frailty Syndrome Clinical Trials

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Start date: May 1, 2011
Phase: N/A
Study type: Interventional

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the health of patients with human frailty syndrome.

NCT ID: NCT01499693 Withdrawn - Gastric pH Control Clinical Trials

Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid Inhibition

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if magnesium pantoprazole 20 mg twice a day (b.i.d.), maintains gastric pH above 4 during a longer percentage of time than magnesium pantoprazole 40 mg once a day (qd). This is a comparison between split dose concept and standard dose of proton pump inhibitors.

NCT ID: NCT01482871 Withdrawn - Clinical trials for Diabetic Macular Edema

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of ophthalmic intravitreal injection of ALG - 1001 in human subjects with diabetic macular edema. The primary endpoint of this study is observation of dose limiting toxicity and maximum tolerated dose. The secondary endpoint of this study is observation of a clinical effect in BCVA (ETDRS letters) and OCT central macular thickness.

NCT ID: NCT01453829 Withdrawn - Stroke Clinical Trials

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke

Start date: October 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients after Stroke and clinical outcomes?

NCT ID: NCT01453816 Withdrawn - Renal Failure Clinical Trials

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure

Start date: May 2011
Phase: N/A
Study type: Interventional

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients with Renal Failure and clinical outcomes